ALS Research Collaboration
ALS Research Collaboration
Home   :   Who We Are   :   ALS Research   :   About ALS   :   Newsletter   :   How You Can Help   :   FAQ   :   News & Events   :   Other Research   :   Contact Us
Overview  |   EPITOME  |   MGTX  |   GWAS  |   Methotrexate   |   Eculizumab  |   SAFNI  |   Cochrane Collaboration  |   HIV Neuropathy  |   Normative Data
Dexpramipexole

Characteristics, Risk Factors and Prevention of HIV Polyneuropathy in South Africa (HIV Neuropathy)

 

Principal Investigator

Jeannine Heckmann, MD, PhD

Site-PI

Taylor Harrison, MD
Michael Benatar, MD, PhD

Summary

HIV and Tuberculosis are endemic in South Africa.  An epidemic of HIV-associated neuropathy is anticipated in the context of use of stavudine-containing anti-retroviral regimens. Our preliminary goals are to investigate risk factors for HIV neuropathy such as concurrent tuberculosis infection, prior or ongoing anti-TB therapy and nutritional deficiency.

Eligibility criteria

  • HIV positive
  • Anti-retroviral drug naive
  • Age > 18 years

Funding agency

Emory Global Health Institute, Emory University Research Committee

Collaborators

Jeannine Heckman, MD, PhD
Taylor Harrison, MD
Joel Dave, MD

Project manager

 

Contact information

Email: mbenatar@med.miami.edu

Links

 

Presentations / Publications

  • Jean Maritz, Michael Benatar, Joel Dave, Taylor Harrison, Motasim Badri, Naomi Levitt, Jeannine Heckmann, HIV Neuropathy in South Africans: Frequency, Characteristics and Risk Factors (Muscle & Nerve, in press)
 
Copyright © 2010 ARC Website. All Rights Reserved. Site designed by Academic Web Pages.